Skip to main content
SpringerLink
Log in

Seronegative Celiac Disease: Increased Prevalence with Lesser Degrees of Villous Atrophy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Our aim was to assess differences in the sensitivities of serologic tests used for the diagnosis of celiac disease among patients with varying degrees of villous atrophy. Among 115 adults with biopsy-proven celiac disease who fulfilled strict criteria, including serologic testing at the time of diagnosis and response to a gluten-free diet, 71% had total villous atrophy and 29% partial villous atrophy. Endomysial antibody was positive in 77% of those with total villous atrophy, compared to 33% with partial villous atrophy (P < 0.001). There was no difference in sensitivity when the type of presentation (classical vs. silent) was compared. Endomysial antibody-positive and negative patients did not differ with respect to age at diagnosis, duration of symptoms, mode of presentation, or family history of celiac disease. All anti-tissue transglutaminase-positive patients had TVA on biopsy. Seronegative celiac disease occurs. Endomysial antibody positivity correlates with more severe villous atrophy and not mode of presentation of celiac disease. Serologic tests, in clinical practice, lack the sensitivity reported in the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sanders DS, Carter MJ, Hurlstone DP, et al.: Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 358(9292):1504-1508, 2001

    Google Scholar 

  2. Lo W, Sano K, Lebwohl B, Diamond B, Green PH: Changing presentation of adult celiac disease. Dig Dis Sci 48(2):395-398, 2003

    Google Scholar 

  3. Alaedini A, Green PH, Sander HW, et al.: Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol 127(1–2):145-148, 2002

    Google Scholar 

  4. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al.: Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352(9140):1582-1585, 1998

    Google Scholar 

  5. Unsworth DJ, Lock RJ, Harvey RF: Improving the diagnosis of coeliac disease in anaemic women. Br J Haematol 111(3):898-901, 2000

    Google Scholar 

  6. Meyer D, Stavropolous S, Diamond B, Shane E, Green PH: Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol 96(1):112-119, 2001

    Google Scholar 

  7. Walker-Smith JA GS, Schmerling DM, Visakorpi JK: Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65(8):909-911, 1990

    Google Scholar 

  8. Murray JA: Serodiagnosis of celiac disease. Clin Lab Med 17(3):445-464, 1997

    Google Scholar 

  9. Dieterich W, Ehnis T, Bauer M, et al.: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3(7):797-801, 1997

    Google Scholar 

  10. American Gastroenterological Association medical position statement: Celiac Sprue. Gastroenterology 120(6):1522-1525, 2001

  11. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ: Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94(4):888-894, 1999

    Google Scholar 

  12. Dahele A, Kingstone K, Bode J, Anderson D, Ghosh S: Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig Dis Sci 46(1):214-221, 2001

    Google Scholar 

  13. Dahele AV, Aldhous MC, Humphreys K, Ghosh S: Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. Q J Med 94(4):195-205, 2001

    Google Scholar 

  14. Shamir R, Lerner A, Shinar E, et al.: The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol 97(10):2589-2594, 2002

    Google Scholar 

  15. Dickey W, Hughes DF, McMillan SA: Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 35(2):181-183, 2000

    Google Scholar 

  16. Murray JA, Herlein J, Mitros F, Goeken JA: Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol 7(4):584-587, 2000

    Google Scholar 

  17. Marsh MN: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102(1):330-354, 1992

    Google Scholar 

  18. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G: Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 17(2):123-127, 1993

    Google Scholar 

  19. Rubin CE: Some reflections on reversibility, gluten and the intestine. Gastroenterology 39:260-261, 1960

    Google Scholar 

  20. MacDonald WC BL, Flick AL, Trier JS, Rubin CE.: Studies of celiac sprue. IV. The response of the whole length of the small bowel to a gluten-free diet. Gastroenterology 47:573-589, 1964

    Google Scholar 

  21. Regan PT, DiMagno EP: Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure. Gastroenterology 78(3):484-487, 1980

    Google Scholar 

  22. Murray JA: It's not time to put away the biopsy forceps. Am J Gastroenterol 94(4):869-871, 1999

    Google Scholar 

  23. Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P: Endomysial antibody: is it the best screening test for coeliac disease? Gut 33(12):1633-1637, 1992

    Google Scholar 

  24. Whelan A, Willoughby R, Weir D: Human umbilical vein endothelial cells: a new easily available source of endomysial antigens. Eur J Gastroenterol Hepatol 8(10):961-966, 1996

    Google Scholar 

  25. Kumar V, Lerner A, Valeski JE, Beutner EH, Chorzelski TP, Rossi T: Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers. Immunol Invest 18(1–4):533-544, 1989

    Google Scholar 

  26. Dieterich W, Laag E, Schopper H, et al.: Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115(6):1317-1321, 1998

    Google Scholar 

  27. Sulkanen S, Halttunen T, Laurila K, et al.: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115(6):1322-1328, 1998

    Google Scholar 

  28. Lock RJ, Pitcher MC, Unsworth DJ: IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol 52(4):274-277, 1999

    Google Scholar 

  29. Biagi F, Ellis HJ, Yiannakou JY, et al.: Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol94(8):2187-2192, 1999

    Google Scholar 

  30. Rostami K, Kerckhaert JP, Tiemessen R, Meijer JW, Mulder CJ: The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 11(4):439-442, 1999

    Google Scholar 

  31. Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H: Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies. J Pediatr Gastroenterol Nutr 33(3):276-282, 2001

    Google Scholar 

  32. Tursi A, Brandimarte G, Giorgetti GM: Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36(3):219-221, 2003

    Google Scholar 

  33. Dickey W, McMillan SA, Hughes DF: Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease. Scand J Gastroenterol 36(5):511-514, 2001

    Google Scholar 

  34. Green PH, Barry M, Matsutani M: Serologic tests for celiac disease. Gastroenterology 124(2):585-586, 2003

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Julian A. Abrams, Beverly Diamond & Peter H. R. Green

  2. Department of Surgical Pathology, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Heidrun Rotterdam

Authors
  1. Julian A. Abrams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beverly Diamond
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heidrun Rotterdam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter H. R. Green
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abrams, J.A., Diamond, B., Rotterdam, H. et al. Seronegative Celiac Disease: Increased Prevalence with Lesser Degrees of Villous Atrophy. Dig Dis Sci 49, 546–550 (2004). https://doi.org/10.1023/B:DDAS.0000026296.02308.00

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000026296.02308.00

Search

Navigation